A Phase 1, Multiple Ascending Dose Study to Evaluate HMS1005 in Participants With Type 2 Diabetes

Clinical trial NCT07568678 · RECRUITING

Trial details

NCT number: NCT07568678
Sponsor: Hua Medicine Limited
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2025-12-04
Primary completion: 2026-08-13
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.